查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405914

美国体外诊断市场规模、份额、趋势分析报告：按产品、技术、应用、最终用途、细分市场预测，2024-2030

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 358 Pages | 商品交期: 2-10个工作天内

价格

美国IVD 市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，美国体外诊断市场规模预计将达到375.8亿美元。

预计2024年至2030年该市场将以3.70%的复合年增长率成长。对血液、尿液和组织等生物液体进行诊断测试的医疗设备称为体外诊断 (IVD)。 IVD 测试用于药物治疗研究以及感染疾病、自体免疫疾病和各种医疗状况的识别和评估。

慢性病和致病性疾病盛行率的上升、人口高龄化、即时检测的普及以及个人化医疗预计将增加该国体外诊断药物（IVD）检测的需求。此外，随着基因组学和蛋白​​质组学的进步，随着分子诊断扩大其范围并引入各种新的病理特异性指标和测试，该行业正在寻找新的视野。

有些疾病变得越来越常见，包括遗传、心血管和神经系统疾病。据美国疾病管制与预防中心 (CDC) 称，心血管疾病 (CVD) 是美国的首要死因，每年估计有 659,000 人死亡。因此，大众早期诊断意识不断增强，常规诊断不断增强，这两者都支撑着整个市场的发展。

先进体外诊断药物的推出正在推动市场快速扩张。此外，市场参与企业和研究机构正在积极致力于开发新产品，以减轻该国的整体疾病负担。例如，2021年5月，加州大学开发了一种超灵敏的分子测试。该测试基于晶片技术，可以检测甲型流感和SARS-CoV-2抗原的存在。进一步的研究正在进行中，旨在将该测试转化为 PoC（护理点）测试。

即时检测机构采用 IVD 检测的情况正在迅速增加。随着多家公司专注于推出居家照护设施的测试，该行业的动态正在改变。此外，2021年，FDA也优先考虑了家庭分子诊断测试。 2021 年 3 月，BATM Advanced Communications Limited 宣布推出用于检测 COVID-19 的分子诊断自检检测套组。

随着诊断实验室采用全自动工具，这个市场正在增强。与手动或半自动化设备相比，自动化设备具有高度扩充性，满足高性能，减少实验室技术人员的时间，消除批量测试，并为医生提供更快的结果。由于这些优势，市场参与企业越来越多地建造自动化设备。

此外，实验室自动化促进、加速并提高了诊断测试的效率和有效性。从装载检体管到为所有主要测试区域提供观察，综合实验室自动化系统可以处理测试过程的每个部分。随着越来越多的製造商以更广泛的自动化选项进入市场，临床诊断业务中实验室自动化的发展不断加速。

COVID-19 大流行增加了对分子诊断工具的需求，因为它们已被用来检测 SARS-CoV-2 病毒。此外，住院的 COVID-19 患者对测量血糖值、肌钙蛋白和各种其他参数的检测套组和用品的需求激增。因此，在大流行期间体外诊断的使用增加，推动了市场成长。

美国体外诊断市场报告亮点

  • 从产品来看，由于美国对基因检测的需求不断增长以及先进癌症诊断测试​​的可用性，试剂产业在美国体外诊断市场中占有很大份额。
  • 混凝行业预计将快速成长。心血管疾病、血液相关疾病和自体免疫疾病盛行率的上升预计将推动对血液凝固检验的需求。
  • 由于患病率上升以及人们对该疾病早期诊断的认识不断提高，预计癌症行业在预测期内将以最快的复合年增长率增长。
  • 主要市场参与企业包括 QIAGEN、F. Hoffman-La Roche Ltd.、Thermo Fisher Scientific, Inc.、Danaher Corporation 和 Illumina。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国IVD 市场变数、趋势与范围

  • 体外诊断市场前景
    • 母市场展望
  • 法律规范
  • 市场驱动因素分析
    • 老年人口增加
    • 技术进步
    • 对 POC 设施的需求增加
    • 遗传疾病、心血管疾病、神经系统疾病、医院感染等目标疾病盛行率上升
    • 新型冠状病毒感染疾病（COVID-19）的爆发
  • 市场抑制因素分析
    • 设备成本较高
    • 严格的监理政策
  • 价值链分析
    • 价值链分析/市场路径
  • SWOT 分析，按因素（政治/法律、经济、技术）
  • 波特五力分析

第四章美国IVD 市场 - 按产品細項分析，2018-2030

  • 美国体外诊断市场：产品波动分析
  • 装置
    • 2018-2030 年设备市场估计与预测
  • 试剂
    • 2018-2030 年试剂市场估计与预测
  • 服务
    • 2018-2030 年服务市场估计与预测

第五章 2018-2030 年美国IVD 市场細項分析（依技术）

  • 体外诊断市场：技术变革分析
  • 免疫检测
    • 2018-2030 年免疫检测市场估计与预测
    • 装置
    • 试剂
    • 服务
  • 血液学
    • 2018-2030 年血液学市场估计与预测
    • 装置
    • 试剂
    • 服务
  • 临床化学
    • 2018-2030 年临床化学市场估计与预测
    • 装置
    • 试剂
    • 服务
  • 分子诊断
    • 2018-2030 年分子诊断市场估计与预测
    • 装置
    • 试剂
    • 服务
  • 凝固
    • 2018-2030 年混凝市场估计与预测
    • 装置
    • 试剂
    • 服务
  • 微生物学
    • 微生物学市场估计与预测，2018-2030
    • 装置
    • 试剂
    • 服务
  • 其他的
    • 2018-2030 年其他市场估计与预测
    • 装置
    • 试剂
    • 服务

第六章美国IVD 市场：細項分析，依最终用途，2018-2030 年

  • 体外诊断市场：最终用途变异分析
  • 医院
    • 2018-2030 年医院市场估计与预测
    • 按技术分類的医院市场
  • 实验室
    • 2018-2030 年实验室市场估计与预测
    • 实验室市场（按技术）
  • 居家护理
    • 2018-2030 年家庭护理市场估计与预测
    • 按科技分類的居家照护市场
  • 其他的
    • 2018-2030 年其他市场估计与预测
    • 其他市场，依技术分类

第 7 章美国IVD 市场：2018-2030 年按应用細項分析

  • 美国体外诊断市场：应用变化分析
  • 感染疾病
    • 2018-2030 年感染疾病市场估计与预测
  • 糖尿病
    • 2018-2030 年糖尿病市场估计与预测
  • 肿瘤学
    • 2018-2030 年肿瘤学市场估计与预测
  • 心臟病学
    • 2018-2030 年心臟病市场估计与预测
  • 肾臟病学
    • 2018-2030 年肾臟疾病市场估计与预测
  • 自体免疫疾病
    • 2018-2030 年自体免疫疾病市场估计与预测
  • 药检
    • 2018-2030 年药物检测市场估计与预测
  • 血液疾病
    • 2018-2030 年血液疾病市场估计与预测
  • 其他的
    • 2018-2030 年其他市场估计与预测

第八章美国IVD 市场：区域細項分析，2018-2030

  • 区域分析 –美国IVD 市场
    • 美国IVD市场趋势
    • 主要国家趋势
    • 美国的危险因子和主要慢性病
    • 竞争场景
    • 法律规范
    • 赎回场景
    • 2018-2030 年美国IVD 市场估计与预测

第9章竞争分析

  • 参与企业
    • BD
    • 伯乐实验室有限公司
    • 方丈
    • 安捷伦科技有限公司
    • 西门子医疗保健有限公司
    • 凯杰
    • 生物梅里埃
    • 奎德尔有限公司
    • 霍夫曼罗氏有限公司
  • 参与企业概况
  • 财务绩效
  • 产品基准评效
  • 2023 年公司市场占有率分析
  • 策略规划
    • 扩张
    • 获得
    • 产品/服务发布
    • 其他的

第10章分析师的观点

Product Code: GVR-4-68039-256-6

U.S. In Vitro Diagnostics Market Growth & Trends:

The U.S. in vitro diagnostics market size is expected to reach USD 37.58 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 3.70% from 2024 to 2030. Medical instruments that perform diagnostic tests on bio-fluids including blood, urine, and tissues are known as in vitro diagnostics (IVD). The IVD tests are used to study pharmacological therapy and to identify and evaluate infectious diseases, autoimmune disorders, and a variety of medical ailments.

The rising prevalence of chronic and pathogenic diseases, the aging population, the increasing popularity of point-of-care testing, and personalized medicine are anticipated to increase the demand for IVD testing in the country. Moreover, with developments in genomics & proteomics, this industry is seeing new prospects as molecular diagnostics expands its reach and introduces a new variety of condition-specific indicators and tests.

Several ailments, such as genetic, cardiovascular, and neurological disorders, are becoming more common. Cardiovascular diseases (CVDs) are the major cause of death in the U.S., killing an estimated 659,000 people each year, as per the Centers for Disease Control and Prevention (CDC). This has resulted in a significant public awareness about early diagnosis and a rise in routine diagnosis, both of which support the market's overall development.

The launch of new advanced IVD products is assisting the market's rapid expansion. Moreover, market players and research institutes are actively involved in the development of novel products to reduce the overall disease burden in the country. For instance, in May 2021, the University of California developed an ultrasensitive molecular test. This test is based on a chip technology that can detect the presence of influenza A and SARS-CoV-2 antigens. The test is under further study for conversion into a Point-of-Care (PoC) test.

The adoption of IVD testing at the point-of-care testing facilities is increasing rapidly. As several players are focusing on launching tests for home care facilities, there has been a shift in the industry dynamics. Moreover, in 2021, FDA also prioritized home-based molecular diagnostics tests. In March 2021, BATM Advanced Communications Limited announced the launch of its molecular diagnostics self-test kit for the detection of COVID-19.

The market is gaining strength as diagnostic laboratories increasingly employ fully automated tools. Automated instruments, as opposed to manual and semi-automated equipment, are more expandable, meet high level of performance, reduce technologists' hands-on time, eliminate batch testing, and provide faster results to physicians. Market participants are increasingly working on building automated instruments as a result of these benefits.

Furthermore, laboratory automation facilitates, expedites, and improves the efficiency and efficacy of diagnostic tests. From loading specimen tubes to providing findings for all major laboratory disciplines, a total lab automated system can handle all parts of the testing process. As more manufacturers enter the market with broader automation choices, the evolution of lab automation in the clinical diagnostics business is continuing to accelerate.

Since it is utilized to detect the SARS-CoV-2 virus, the COVID-19 pandemic has increased the demand for molecular diagnostics tools. Additionally, among hospitalized patients suffering from COVID-19, there was a surge in demand for test kits and consumables for measuring blood glucose levels, troponin levels, and a variety of other parameters. As a result, the usage of IVD devices increased during the pandemic and propelled the market growth.

U.S. In Vitro Diagnostics Market Report Highlights:

  • By product, the reagent segment held a larger share of the U.S. IVD market owing to the increasing demand for genetic testing and the availability of advanced cancer diagnostic tests in the country
  • The coagulation segment is expected to be the fastest-growing segment. The rising prevalence of cardiovascular diseases, blood-related disorders, and autoimmune diseases is expected to boost the demand for coagulation testing
  • The oncology segment is anticipated to grow at the fastest CAGR over the forecast period owing to the increasing prevalence of disease and increasing awareness among people about early diagnosis of diseases
  • A few of the key market players include QIAGEN; F. Hoffman-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Danaher Corporation; Illumina

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 U.S. IVD Market Variables, Trends, & Scope

  • 3.1 IVD Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Regulatory Framework
  • 3.3 Market Driver Analysis
    • 3.3.1 Growing Geriatric Population
    • 3.3.2 Technological Advancements
    • 3.3.3 Increasing Demand For Poc Facilities
    • 3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
    • 3.3.5 Outbreak Of Covid-19
  • 3.4 Market Restraint Analysis
    • 3.4.1 Higher Cost Of Devices
    • 3.4.2 Stringent Regulatory Policies
  • 3.5 Value Chain Analysis
    • 3.5.1 Value Chain Analysis/Route To Market
  • 3.6 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.7 Porter's Five Forces Analysis

Chapter 4 U.S. IVD Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 U.S. In Vitro Diagnostic Market: Products Movement Analysis
  • 4.2 Instruments
    • 4.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Reagents
    • 4.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Services
    • 4.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 U.S. IVD Market-Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 In Vitro Diagnostics Market: Technology Movement Analysis
  • 5.2 Immunoassay
    • 5.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Instruments
      • 5.2.2.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.3 Reagents
      • 5.2.3.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.4 Services
      • 5.2.4.1 Services Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Hematology
    • 5.3.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.2 Instruments
      • 5.3.2.1 Instruments Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.3 Reagents
      • 5.3.3.1 Reagents Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.4 Services
      • 5.3.4.1 Services Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Clinical Chemistry
    • 5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.2 Instruments
      • 5.4.2.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.3 Reagents
      • 5.4.3.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.4 Services
      • 5.4.4.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Molecular Diagnostics
    • 5.5.1 Moecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Instruments
      • 5.5.2.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.3 Reagents
      • 5.5.3.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.4 Services
      • 5.5.4.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Coagulation
    • 5.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.2 Instruments
      • 5.6.2.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.3 Reagents
      • 5.6.3.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.4 Services
      • 5.6.4.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Microbiology
    • 5.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.2 Instruments
      • 5.7.2.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.3 Reagents
      • 5.7.3.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.4 Services
      • 5.7.4.1 Services Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8 Others
    • 5.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.2 Instruments
      • 5.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.3 Reagents
      • 5.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.4 Services
      • 5.8.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 U.S. IVD Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1 In Vitro Diagnostic Market: End-Use Movement Analysis
  • 6.2 Hospitals
    • 6.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Hospitals Market, By Technology
      • 6.2.2.1 Immunoassay
      • 6.2.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.3 Hematology
      • 6.2.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.5 Clinical Chemistry
      • 6.2.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.7 Molecular Diagnostics
      • 6.2.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.9 Coagulation
      • 6.2.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.11 Microbiology
      • 6.2.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.13 Others
      • 6.2.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Laboratory
    • 6.3.1 Laboratory Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Laboratory Market, By Technology
      • 6.3.2.1 Immunoassay
      • 6.3.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.3 Hematology
      • 6.3.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.5 Clinical Chemistry
      • 6.3.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.7 Molecular Diagnostics
      • 6.3.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.9 Coagulation
      • 6.3.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.11 Microbiology
      • 6.3.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.13 Others
      • 6.3.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Home Care
    • 6.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2 Home Care Market, By Technology
      • 6.4.2.1 Immunoassay
      • 6.4.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.3 Hematology
      • 6.4.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.5 Clinical Chemistry
      • 6.4.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.7 Molecular Diagnostics
      • 6.4.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.9 Coagulation
      • 6.4.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.11 Microbiology
      • 6.4.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.13 Others
      • 6.4.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Others Market, By Technology
      • 6.5.2.1 Immunoassay
      • 6.5.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.3 Hematology
      • 6.5.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.5 Clinical Chemistry
      • 6.5.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.7 Molecular Diagnostics
      • 6.5.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.9 Coagulation
      • 6.5.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.11 Microbiology
      • 6.5.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.13 Others
      • 6.5.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 U.S. IVD Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 7.1 U.S. In Vitro Diagnostics Market: Application Movement Analysis
  • 7.2 Infectious Diseases
    • 7.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.1 Upper Respiratory
      • 7.2.1.1.1 Upper Respiratory Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.2 Gastrointestinal Panel Testing
      • 7.2.1.2.1 Gastrointestinal Panel Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.3 Methicillin-Resistant Staphylococcus Aureus (MRSA)
      • 7.2.1.3.1 MRSA Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.4 Clostridium Difficile
      • 7.2.1.4.1 Clostridium Difficile Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.5 Vancomycin-Resistant Enterococci (VRE)
      • 7.2.1.5.1 VRE Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.6 Carbapenem-Resistant Bacteria
      • 7.2.1.6.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.7 Flu
      • 7.2.1.7.1 Flu Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.8 Respiratory Syncytial Virus (RSV)
      • 7.2.1.8.1 RSV Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.9 Candida
      • 7.2.1.9.1 Candida Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.10 Tuberculosis (TB) And Drug-Resistant TB
      • 7.2.1.10.1 TB And Drug-Resistant TB Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.11 Meningitis
      • 7.2.1.11.1 Meningitis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.12 Chlamydia
      • 7.2.1.12.1 Chlamydia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.13 Gonorrhoea
      • 7.2.1.13.1 Gonorrhoea Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.14 HIV
      • 7.2.1.14.1 HIV Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.15 Hepatitis C
      • 7.2.1.15.1 Hepatitis C Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.16 Hepatitis B
      • 7.2.1.16.1 Hepatitis B Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.17 Other Infectious Diseases
      • 7.2.1.17.1 Other Infectious Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Diabetes
    • 7.3.1 Diabetes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Oncology
    • 7.4.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Cardiology
    • 7.5.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Nephrology
    • 7.6.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.7 Autoimmune Diseases
    • 7.7.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.8 Drug Testing
    • 7.8.1 Drug Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.9 Hematologic Diseases
    • 7.9.1 Hematologic Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.10 Others
    • 7.10.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 U.S. IVD Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Regional Analysis - The U.S. IVD Market
    • 8.1.1 Trends In The U.S. IVD Market
    • 8.1.2 Key Country Dynamics
    • 8.1.3 Risk Factors And Major Chronic Diseases In The U.S.
    • 8.1.4 Competitive Scenario
    • 8.1.5 Regulatory Framework
    • 8.1.6 Reimbursement Scenario
    • 8.1.7 U.S. IVD Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Analysis

  • 9.1. Participant Categorization
    • 9.1.1. BD
      • 9.1.1.1. Overview
      • 9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.1.3. Product Benchmarking
      • 9.1.1.4. Strategic Initiatives
    • 9.1.2. Bio-Rad Laboratories, Inc.
      • 9.1.2.1. Overview
      • 9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.2.3. Product Benchmarking
      • 9.1.2.4. Strategic Initiatives
    • 9.1.3. Abbott
      • 9.1.3.1. Overview
      • 9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.3.3. Product Benchmarking
      • 9.1.3.4. Strategic Initiatives
    • 9.1.4. Agilent Technologies, Inc.
      • 9.1.4.1. Overview
      • 9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.4.3. Product Benchmarking
      • 9.1.4.4. Strategic Initiatives
    • 9.1.5. Siemens Healthcare GmbH
      • 9.1.5.1. Overview
      • 9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.5.3. Product Benchmarking
      • 9.1.5.4. Strategic Initiatives
    • 9.1.6. Qiagen
      • 9.1.6.1. Overview
      • 9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.6.3. Product Benchmarking
      • 9.1.6.4. Strategic Initiatives
    • 9.1.7. bioMerieux
      • 9.1.7.1. Overview
      • 9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.7.3. Product Benchmarking
      • 9.1.7.4. Strategic Initiatives
    • 9.1.8. Quidel Corporation
      • 9.1.8.1. Overview
      • 9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.8.3. Product Benchmarking
      • 9.1.8.4. Strategic Initiatives
    • 9.1.9. F. Hoffmann-La Roche, Ltd.
      • 9.1.9.1. Overview
      • 9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.9.3. Product Benchmarking
      • 9.1.9.4. Strategic Initiatives
  • 9.2. Participant's Overview
  • 9.3. Financial Performance
  • 9.4. Product Benchmarking
  • 9.5. Company Market Share Analysis, 2023
  • 9.6. Strategy Mapping
    • 9.6.1. Expansion
    • 9.6.2. Acquisition
    • 9.6.3. Product/Service Launch
    • 9.6.4. Others

Chapter 10. Analyst View  

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Regulatory framework
  • Table 4 Current oversight of diagnostic tests
  • Table 5 EUA IVD tests for COVID-19 in March and April 2020 (Early Entrants)
  • Table 6 List of FDA approved immunoassays during early stage of pandemic
  • Table 7 List of key distributors
  • Table 8 List of key emerging companies/technology disruptors/innovators
  • Table 9 U.S. in vitro diagnostics market, by product, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)
  • Table 10 U.S. in vitro diagnostics market, by technology, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)
  • Table 11 U.S. in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. in vitro diagnostics market, by end-use, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)

List of Figures

  • Fig. 1 U.S. in vitro diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. in vitro diagnostics market outlook (2023)
  • Fig. 10 Parent market outlook, 2023
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Taking control of the changing regulatory landscape
  • Fig. 13 In vitro diagnostic market driver impact
  • Fig. 14 Geriatric population in the U.S.
  • Fig. 15 In vitro diagnostics market restraint impact
  • Fig. 16 Market entry strategy
  • Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Strategy mapping
  • Fig. 20 U.S. in vitro diagnostics market: Product outlook and key takeaways
  • Fig. 21 U.S. in vitro diagnostics market: Products movement analysis
  • Fig. 22 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 23 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 24 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. in vitro diagnostics market: Technology outlook and key takeaways
  • Fig. 26 U.S. in vitro diagnostics market: Technology movement analysis
  • Fig. 27 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 29 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 30 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 33 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 34 Services market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 37 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 38 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 41 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 42 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 45 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 46 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 49 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 50 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Instruments others market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 53 Reagents others market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 54 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. in vitro diagnostics market: End-use outlook and key takeaways
  • Fig. 56 U.S. in vitro diagnostics market: End-use movement analysis
  • Fig. 57 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 60 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 61 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 64 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 65 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 68 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 69 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 72 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 73 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 76 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 77 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 80 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 81 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 84 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 85 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Laboratory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 89 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 90 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 93 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 94 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 97 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 98 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 101 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 102 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 105 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 106 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 109 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 110 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 113 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 114 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 116 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 117 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 118 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 119 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 120 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 121 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 122 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 123 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 124 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 126 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 127 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 128 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 130 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 131 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 132 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 134 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 135 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 136 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 137 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 138 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 139 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 140 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 141 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 142 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 143 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 144 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 145 U.S. in vitro diagnostics market: Application outlook and key takeaways
  • Fig. 146 U.S. in vitro diagnostics market: Application movement analysis
  • Fig. 147 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 148 Upper respiratory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 149 Gastrointestinal panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 150 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 151 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 152 VRE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 153 Carbapenem-resistant bacteria market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 154 Flu market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 155 RSV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 156 Candida market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 157 TB and drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 158 Meningitis cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 159 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 160 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 161 HIV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 162 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 163 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 164 Other infectious disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 165 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 166 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 167 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 168 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 169 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 170 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 171 Hematologic diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 172 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 173 U.S. in vitro diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 174 Competition categorization
  • Fig. 175 Company market share analysis, 2023